Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: Review of the literature of human papillomavirus detection in these carcinomas
Corresponding Author
Kanako Ogura
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Kanako Ogura, MD, Department of Pathology (I), Juntendo University, School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan. Email: [email protected]Search for more papers by this authorToshiharu Matsumoto
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Search for more papers by this authorMichio Nojima
Obstetrics and Gynecology, Juntendo Urayasu Hospital, Chiba, Japan
Search for more papers by this authorKoichi Suda
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Search for more papers by this authorCorresponding Author
Kanako Ogura
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Kanako Ogura, MD, Department of Pathology (I), Juntendo University, School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan. Email: [email protected]Search for more papers by this authorToshiharu Matsumoto
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Search for more papers by this authorMichio Nojima
Obstetrics and Gynecology, Juntendo Urayasu Hospital, Chiba, Japan
Search for more papers by this authorKoichi Suda
Department of Pathology (I), School of Medicine, Juntendo University, Tokyo and Departments of
Search for more papers by this authorAbstract
Many studies have suggested that human papillomavirus (HPV) infection plays an important role in the carcinogenesis of the cervical adenocarcinoma. However, the prevalence of HPV infection in cervical adenocarcinoma and adenosquamous carcinoma varies among the studies. Cervical adenocarcinoma (24 cases) and adenosquamous carcinoma (16 cases), including the underlying non-neoplastic epithelium were examined for HPV-DNA using in situ polymerase chain reaction (PCR), which enabled visualization of the localization on a glass slide. In adenocarcinoma, HPV-DNA was found in 13 cases (54%) and in eight cases in underlying non-neoplastic epithelium, resulting in a total of 21 positive cases (88%). In adenosquamous carcinoma, HPV-DNA was detected in 12 cases (75%) and and the HPV-DNA localization of each component was pure adenocarcinoma, 28.6%; mixed, 54.5%; and pure squamous cell carcinoma, 83.3%. In the underlying non-neoplastic epithelium, HPV-DNA was found more frequently in the squamous epithelium (73.3%) than the cervical glands (6.3%). In conclusion, HPV-DNA was detected in 54% of adenocarcinoma, and the rate was elevated by HPV localization in the underlying non-neoplastic epithelium. HPV infection in the underlying squamous epithelium might be related to the carcinogenesis, even in cervical adenocarcinoma. HPV-DNA localization was different in each component of adenosquamous carcinoma.
REFERENCES
- 1 Wallboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19.
- 2 Daniel B, Mukherjee G, Seshadri L, Vallikad E, Krishna S. Change in the physical state and expression of human papillomavirus type 16 in the progression of cervical intraepithelial neoplasia lesions analysed by PCR. J Gen Virol 1995; 76: 2589–93.
- 3 Klaes R, Woerner SM, Ridder R et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999; 59: 6132–6.
- 4 Zheng T, Holford TR, Ma Z et al. The continuing increase in adenocarcinoma of the uterine cervix: A birth cohort phenomenon. Int J Epidemiol 1996; 25: 252–8.
- 5
Teshima S,
Shimosato Y,
Kishi K,
Kasamatsu T,
Ohmi K,
Uei Y.
Early stage adenocarcinoma of the uterine cervix. Histopathologic analysis with consideration of histogenesis.
Cancer
1985; 56: 167–72.
10.1002/1097-0142(19850701)56:1<167::AID-CNCR2820560126>3.0.CO;2-T PubMed Web of Science® Google Scholar
- 6 Parazzini F, Vecchia CL. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1989; 39: 40–46.
- 7
Lee KR,
Flynn CE.
Early invasive adenocarcinoma of the cervix. A histopathologic analysis of 40 cases with observations concerning histogenesis.
Cancer
2000; 89: 1048–55.
10.1002/1097-0142(20000901)89:5<1048::AID-CNCR14>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 8 Ishi K, Kina K, Koyatsu J et al. Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction. Rinsho Byori 1997; 45: 82–6 (in Japanese).
- 9 Ogura K, Ishi K, Suzuki F et al. The relationship with human papilloma virus DNA in cervical adenocarcinoma. Rinsho Byori 2004; 52: 115–19 (in Japanese).
- 10 Wells M, Nesland JM, Ostor AG et al. Epithelial tumors. In: FA Tavassoli, P Devilee, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003; 262–79.
- 11 An HJ, Kim KR, Kim IS et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: A population-based study. Mod Pathol 2005; 18: 528–34.
- 12 Zielinski GD, Snijders PJF, Rozendaal L et al. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003; 201: 535–43.
- 13 Pirog EC, Kleter B, Olgac S et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adneocarcinoma. Am J Pathol 2000; 157: 1055–62.
- 14 Schorge JO, Lea JS, Elias KJ et al. P16 as a molecular biomarker of cervical adenocarcinoma. Am J Obstet Gynecol 2004; 190: 668–73.
- 15 Riethdorf S, Riethdorf L, Milde-Langosch K, Park T, Loning T. Differences in HPV16- and HPV18 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Arch 2000; 437: 491–500.
- 16 Gordon AN, Bornstein J, Kaufman RH, Estrada RG, Adams E, Adler-Storthz K. Human papillomavirus associated with adenocarcinoma and adenosquamous carcinoma of the cervix: Analysis by in situ hybridization. Gynecol Oncol 1989; 35: 345–8.
- 17 Johnson TL, Kim W, Plieth DA, Sarkar FH. Detection of HPV16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992; 5: 35–40.
- 18 Ansari-Lari MA, Staebler A, Zaino RJ, Shah KV, Ronnett BM. Distinction of endocervical and endometrial adenocarcinomas. Immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection. Am J Surg Pathol 2004; 28: 160–67.
- 19 Cambruzzi E, Zettler CG, Alexandre COP. Expression of Ki-67 and squamous intraepithelial lesions are related with HPV in endocervical adenocarcinoma. Pathol Oncol Res 2005; 11: 114–20.
- 20 Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer 2001; 37: 246–50.
- 21 Tenti P, Pavanello S, Padovan L et al. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Am J Pathol 1998; 152: 1057–63.
- 22
Iwasawa A,
Nieminen P,
Lehtinen M,
Paavonen J.
Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Cancer
1996; 77: 2275–9.
10.1002/(SICI)1097-0142(19960601)77:11<2275::AID-CNCR14>3.0.CO;2-U PubMed Web of Science® Google Scholar
- 23 Milde-Langosch K, Riethdorf S, Kraus-Poppinghaus A, Riethdorf L, Loning T. Expression of cyclin-dependent kinase inhibitors p16MTS1, 21WAF1 and p27KIP1 in HPV–positive and HPV–negative cervical adenocarcinomas. Virchows Arch 2001; 439: 55–61.
- 24 Horging U, Daugaard S, Visfeldt J. Adenocarcinoma of the cervix and adneocarcinoma of the endometrium: Distinction with PCR-mediated detection of HPV DNA. APMIS 1997; 105: 313–16.
- 25 Ishikawa M, Fujii T, Masumoto N et al. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 2003; 22: 378–85.
- 26 Duggan MA, Mcgregor SE, Benoit JL, Inoue M, Nation JG, Stuart GCE. The human papillomavirus status of invasive cervical adenocarcinoma: A clinicopathological and outcome analysis. Hum Pathol 1995; 26: 319–25.
- 27 Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1998; 11: 11–18.
- 28 Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994; 53: 190–95.
- 29 Jiko K, Tsuda H, Sato S, Hirohashi S. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papilloma virus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int J Cancer 1994; 59: 601–6.
- 30 Tase T, Okagaki T, Clark BA et al. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: A study by in situ DNA hybridization. Cancer Res 1988; 48: 993–8.
- 31 Teshima H, Beaudenon S, Koi K et al. Human papillomavirus type 18 DNA sequences in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Arch Gynecol Obstet 1997; 259: 169–77.
- 32 Lee MF, Chang MC, Wu CH. Detection of human papillomavirus types in cervical adenocarcinoma by the polymerase chain reaction. Int J Gynecol Obset 1998; 63: 265–70.
- 33 Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997; 65: 23–9.
- 34 Griffin NR, Dockey D, Lewis FA, Wells M. Demonstration of low frequency of human papillomavirus DNA in cervical adenocarcinoma and adenocarcinoma in situ by the polymerase chain reaction and in situ hybridization. Int J Gynecol Pathol 1991; 10: 36–43.
- 35 Leminen A, Paavonen J, Vesterinen E, Wahlstrom T, Rantala I, Lehtinen M. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Am J Clin Pathol 1991; 95: 647–52.
- 36 Young FI, Ward LM, Brown LJR. Absence of human papilloma virus in cervical adenocarcinoma determined by in situ hybridization. J Clin Pathol 1991; 44: 340–41.
- 37 Kina K, Ishi K, Okazaki T et al. Comparison of PCR-ISH and in situ PCR in cytodiagnosis specimens: A basic study on these methods and their clinical application. Rinsho Byori 1996; 35: 32–7 (in Japanese).
Citing Literature
